Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29
Viekira Pak (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug.
Drug patent litigation for VIEKIRA PAK (COPACKAGED).
This drug has five hundred and forty-eight patent family members in fifty-three countries.
The generic ingredient in VIEKIRA PAK (COPACKAGED) is dasabuvir sodium; ombitasvir, paritaprevir, ritonavir. One supplier is listed for this compound. Additional details are available on the dasabuvir sodium; ombitasvir, paritaprevir, ritonavir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
